Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1996-09-16
1998-05-05
Feisee, Lila
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 4, 435 72, 435 721, 435 723, 435 792, 530350, 5303881, C07K 1600, G01N 3353, G01N 33567, C12Q 100
Patent
active
057472645
ABSTRACT:
The present invention provides a new method for diagnosing and treating cancers or BPH. Further provided are therapeutic agents and pharmaceutical compositions for treating cancers and BPH.
REFERENCES:
Yamashita, S. et al., "Elevation of serum group II phospholipase A.sub.2 levels in patients with advanced cancer", Clinica Chimica Acta, 1994, 228:91-99.
Faas, F.H. et al., "Increased Phospholipid Fatty Acid Remodeling in Human and Rat Prostatic Adenocarcinoma Tissues", J. Urology, 1996, 156:243-248.
Oka, Y., et al., "Serum Immunoreactive Pancreatic Phospholipase A.sub.2 in Patients with Various Malignant Tumors", Enzyme, 1990, 43:80-88.
Ogawa, M., et al., "Evelation of Serum Group II Phospholipase A.sub.2 in Patients With Cancers of Digestive Organs", Research Communications in Chemical Pathology and Pharmacology, 1991, vol. 74, No. 2, pp. 241-244.
Nevalainen, Timo J., "Serum Phospholipases A.sub.2 in Inflammatory Diseases", Clin. Chem., 1993, 39(12):2453-2459.
Yamashita, J. I., et al., "Overexpression of group II phospholipase A.sub.2 in human breast cancer tissues is closely associated with their malignant potency", Br.J. Cancer, 1994, 69:1166-1170.
Pruzanski, W., et al., "Circulating Group II Phospholipase A.sub.2 Activity and Antilipocortin Antibodies in Systemic Lupus Erythematosus. Correlative Study with Disease Activity", The J. Rheumatol., 1994, 21:252-257.
Ying, Z., et al., "Enhanced expression of group II phospholipase A.sub.2 in human hepatocellular carcinoma", Biochimica et Biophysica Acta, 1994, 1226:201-205.
Minami, T., et al., "Evelation of Phospholipase A.sub.2 Protein in Sera of Patients with Crohn's Disease and Ulcerative Colitis", J. of Gastroenterology, 1993, 88:7.
Kiyohara, H. et al., "Immunohistochemical Localization of Group II Phospholipase A.sub.2 in Human Pancreatic Carcinomas", International J. of Pancreatology, 1993, 13(1):49-57.
Kennedy, B. P., et al., "A Natural Disruption of the Secretory Group II Phospholipase A.sub.2 Gene in Inbred Mouse Strains", J. of Bio. Chemistry, 1995, 270(38):22378-22385.
Hendrickse, C. W., et al., "Activities of phospholipase A.sub.2 and diacylglycerol lipase are increased in human colorectal cancer", British J. of Surgery, 1995, 82:475-478.
Stommer (Klinische Wochenschrift), 1989, 67:136-40.
Ying et al. (Biochimica et Biophysica Acta, 1994, 1226:201-205.
Schmidt Carl J.
Tobin Frank
Wilkinson Francis E.
Feisee Lila
Han William T.
King William T.
Lentz Edward T.
SmithKline Beechum Corporation
LandOfFree
Method of diagnosing and monitoring prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing and monitoring prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing and monitoring prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-52704